X

Vous n'êtes pas connecté

Maroc Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 12/Sep 13:29

RANZCR: AI used for treatment must have doctor oversight

Artificial intelligence (AI) comes with risks as well as benefits, but must have specialist doctor oversight when treating patients, says the Royal Australian and New Zealand College of Radiologists (RANZCR). The College has released two new position statements to guide radiologists and radiation oncologists on the use of autonomous AI and generative AI in clinical [...]

Articles similaires

RANZCR: AI used for treatment must have doctor oversight

oncologynews.com.au - 12/Sep 13:29

Artificial intelligence (AI) comes with risks as well as benefits, but must have specialist doctor oversight when treating patients, says the Royal...

Sorry! Image not available at this time

5 Essential Skills Every Medical Dosimetrist Should Have

healthtechzone.com - 05/Sep 14:50

Precision in radiation treatment plans is central to cancer patient care, carried out by medical dosimetrists who collaborate closely with specialists...

The EU Artificial Intelligence Act: AI In The Balance – Analysis

eurasiareview.com - 06/Sep 23:40

By Meghna Pradhan There has been a rising alarm regarding the scale at which Artificial Intelligence (AI) technology now permeates every aspect of...

Stakeholders’ collaborations vital to cancer care delivery in Nigeria – ARCON

newslineng.com.ng - 11/Sep 17:16

By Chidinma Ewunonu-Aluko, Ibadan The National President of Association of Radiation and Clinical Oncologists in Nigeria (ARCON), Dr Nwamaka...

Stakeholders’ collaborations vital to cancer care delivery in Nigeria – ARCON

veracity.com.ng - 11/Sep 17:07

By Chidinma Ewunonu-AlukoThe National President of Association of Radiation and Clinical Oncologists in Nigeria (ARCON), Dr Nwamaka Lasebikan,...

Sorry! Image not available at this time

First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma

drugs.com - 09/Sep 20:09

HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...

B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

news.medical.net - 12/Sep 18:21

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and...

Sorry! Image not available at this time

Chemistree Solutions: Clinical Specialist

pharmiweb.com - 09/Sep 00:00

Competitive: Chemistree Solutions: Clinical Specialist - Gynaecology. Exciting new opportunity working across North UK and Midlands Role: Clinical...

Sorry! Image not available at this time

Chemistree Solutions: Clinical Specialist

pharmiweb.com - 09/Sep 00:00

Competitive: Chemistree Solutions: Clinical Specialist - Gynaecology. Exciting new opportunity working across North UK and Midlands Role: Clinical...

How Many People Have A-Fib? Three Times More Than We Thought

eurasiareview.com - 11/Sep 22:08

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...

Les derniers communiqués

  • Aucun élément